Cargando…
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus 19 disease (COVID-19) which presents a large spectrum of manifestations with fatal outcomes in vulnerable people over 70-years-old and with hypertension, diabetes, obesity, cardiovascular disease, COPD, and smok...
Autores principales: | Zamorano Cuervo, Natalia, Grandvaux, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652413/ https://www.ncbi.nlm.nih.gov/pubmed/33164751 http://dx.doi.org/10.7554/eLife.61390 |
Ejemplares similares
-
Redox proteomics and structural analyses provide insightful implications for additional non-catalytic thiol-disulfide motifs in PDIs
por: Cuervo, Natalia Zamorano, et al.
Publicado: (2022) -
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
por: Sanders, David W, et al.
Publicado: (2021) -
SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract
por: An, Xiang, et al.
Publicado: (2021) -
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021) -
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)